Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

MLA

Marcus Schmidt, et al. “Prognostic Impact of CD4-Positive T Cell Subsets in Early Breast Cancer: A Study Based on the FinHer Trial Patient Population.” Breast Cancer Research, vol. 20, no. 1, Feb. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13058-018-0942-x.

APA

Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J. Battista, Annette Hasenburg, Ugur Sahin, Konstantine T. Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M. Wirtz, & Heikki Joensuu. (2018). Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population. Breast Cancer Research, 20(1), 1–10. https://doi.org/10.1186/s13058-018-0942-x

Chicago

Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, et al. 2018. “Prognostic Impact of CD4-Positive T Cell Subsets in Early Breast Cancer: A Study Based on the FinHer Trial Patient Population.” Breast Cancer Research 20 (1): 1–10. doi:10.1186/s13058-018-0942-x.